- 
				Utilization of High Terminal Creatinine Kidney Donors for Simultaneous Kidney and Pancreas Transplantation
- 
				Utilization of Kidneys from Deceased Donors with Positive Hepatitis C Nucleic Acid Amplification Testing (HCV NAT+)
- 
				Utilization of Kidneys with Microthrombi and Acute Kidney Injury
- 
				Utilization of Mechanical Circulatory Support Devices and Impact on Outcomes in the New Heart Allocation System: An Analysis of the UNOS Registry
- 
				Utilization of Organs from Donors Exposed to Hepatitis C: ? Standard of Care
- 
				Vaccine Safety Concerns and Relationship to Comfort with Provider Communication in a Population of Inner-City Kidney Transplant Recipients
- 
				Valganciclovir for Epstein-Barr Virus Prevention after Pediatric Kidney Transplant
- 
				Valganciclovir Prophylaxis is Not Associated with Polyomavirus Viremia after Renal Transplantation
- 
				Validation of New Measures of Self-Efficacy and Decision-Making for Living Donors
- 
				Validation of Ontario Marginalization Index Generated from 3-Digit Postal Code in Patients with End-Stage Kidney Disease
- « Previous Page
- 1
- …
- 216
- 217
- 218
- 219
- 220
- …
- 223
- Next Page »
